openPR Logo
Press release

Genomic Data Analysis And Interpretation Market Set to Reach $2.42 Billion by 2029 with 13.3% Yearly Growth

03-20-2025 03:47 AM CET | Health & Medicine

Press release from: The Business Research Company

Genomic Data Analysis And Interpretation Market

Genomic Data Analysis And Interpretation Market

How Are the key drivers contributing to the expansion of the genomic data analysis and interpretation market?
The increasing number of cancer cases is anticipated to drive the genomic data analysis and interpretation market. Cancer, the uncontrolled growth of abnormal cells, is rising due to factors like aging populations, lifestyle changes, and improved diagnostic methods. Genomic data analysis helps identify genetic mutations and biomarkers to create personalized treatment plans. For example, the National Cancer Institute projected that by 2032, there will be 22.5 million cancer survivors in the U.S., up from 18.1 million in 2024. This rise in cancer cases is driving the genomic data analysis and interpretation market.

Get Your Genomic Data Analysis And Interpretation Market Report Here:
https://www.thebusinessresearchcompany.com/report/genomic-data-analysis-and-interpretation-global-market-report

What growth opportunities are expected to drive the genomic data analysis and interpretation market's CAGR through 2034?
The genomic data analysis and interpretation market has experienced rapid expansion. It will increase from $1.29 billion in 2024 to $1.47 billion in 2025, at a CAGR of 13.5%. This growth is attributed to the increasing popularity of direct-to-consumer genetic testing, growing public interest in genomics, the rapid advancement of next-generation sequencing technologies, expanding applications of genomics in oncology, and rising FDA approvals for genomic-based diagnostics and treatments.

The genomic data analysis and interpretation market is expected to grow to $2.42 billion by 2029, at a CAGR of 13.3%. Growth is driven by personalized medicine demand, R&D growth, high-throughput sequencing, genetic testing awareness, and genomics in agriculture. Key trends include multi-omics data integration, AI and machine learning, epigenomic analysis, cloud-based platforms, and pharmacogenomics.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15575&type=smp

What are the emerging trends shaping the future of the genomic data analysis and interpretation market?
Companies in the genomic data analysis and interpretation market are focusing on providing innovative services, such as advanced long-read sequencing, to stay competitive. In April 2024, Clinical-Microbiomics A/S, a Denmark-based biotech company, launched Advanced Long-Read 16S, ITS, 18S, Isolate, and metagenomics sequencing services. These services deliver higher-resolution insights into microbial communities, allowing for more precise identification of organisms and providing a better understanding of microbial ecosystems.

Which growth-oriented segments of the genomic data analysis and interpretation market are leading the industry's development?
The genomic data analysis and interpretation market covered in this report is segmented -

1) By Product: Software, Services
2) By Application: Functional Genomics, Real-time Polymerase Chain Reaction (PCR), Transfection, Single Nucleotide Polymorphisms (SNP) Analysis, Mutational Analysis, Microarray Analysis, Ribonucleic Acid (RNA) Interference, Pathway Analysis
3) By End User: Research And Academic Institutions, Biotechnology And Biopharmaceutical Companies, Hospitals And Diagnostic Laboratories, Contract Research Organizations, Forensic Laboratories, Other End Users

Subsegments:
1) By Software: Data Analysis Software, Genome Sequencing Software, Bioinformatics Software, Variant Analysis Software, Cloud-Based Genomic Software, Other Software Solutions
2) By Services: Genomic Data Analysis Services, Genome Sequencing Services, Bioinformatics Services, Consulting Services, Interpretation And Reporting Services, Cloud-Based Genomic Services, Other Services

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15575

Which regions are key players in the growth of the genomic data analysis and interpretation market?
North America was the largest region in the genomic data analysis and interpretation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomic data analysis and interpretation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What companies are at the forefront of innovation in the genomic data analysis and interpretation market?
Major companies operating in the genomic data analysis and interpretation market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Beijing Genomics Institute (BGI) Genomics Co. Ltd., Guardant Health Inc., 10x Genomics Inc., Oxford Nanopore Technologies Inc., Pacific Biosciences of California Inc., SOPHiA GENETICS Inc., DNAnexus Inc., Seven Bridges Genomics Inc., ASURAGEN INC., Fabric Genomics Inc., DNASTAR Inc., Genoox, Golden Helix Inc., Partek Inc., SoftGenetics LLC, Cantada Bio, Geneyx Genomex Ltd., Freenome Holdings Inc., BlueBee Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=15575&type=smp

What Is Covered In The Genomic Data Analysis And Interpretation Global Market Report?

•Market Size Forecast: Examine the genomic data analysis and interpretation market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the genomic data analysis and interpretation market for a structured understanding.
•Key Players Overview: Analyze major players in the genomic data analysis and interpretation market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the genomic data analysis and interpretation market.
•Segment Contributions: Evaluate how different segments drive overall growth in the genomic data analysis and interpretation market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the genomic data analysis and interpretation market.
•Industry Challenges: Identify potential risks and obstacles affecting the genomic data analysis and interpretation market.
•Competitive Landscape: Review strategic developments in the genomic data analysis and interpretation market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Genomic Data Analysis And Interpretation Market Set to Reach $2.42 Billion by 2029 with 13.3% Yearly Growth here

News-ID: 3925461 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Genomic

Genomic Cancer Testing Market Insights on the Impact of Genomic Profiling and Bi …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Genomic Cancer Testing Market - (By Test Type (Genomic Profiling Tests, Liquid Biopsy Tests, Companion Diagnostic Tests, Pharmacogenomic Tests, Hereditary Cancer Tests, Other specialized genomic tests), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Ovarian Cancer, Melanoma, Leukemia, Lymphoma, Other specific cancer types), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR),
Japan Genomic Medicine Market 2025 | Hospitals & clinics lead with 53% share, ad …
Leander, Texas and Tokyo, Japan - Nov.27.2025 As per DataM intelligence research report" Japan Genomic Medicine Market to expected to grow at High CAGR during forecast period 2024-2031." Personalized treatment approaches and advanced research investments are boosting genomic medicine adoption in Japan. Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/japan-genomic-medicine-market?Prasad Japan: Recent Industry Developments ✅ In November 2025, Takeda Pharmaceutical advanced genomic-guided therapies for rare hereditary diseases, improving precision in
Genomic and Epigenomic Profiling Market Development Driven by Investment in Biot …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Genomic & Epigenomic Profiling Market Size, Share & Trends Analysis Report, By Type (Genomic Profiling and Epigenomic Profiling), By Application (Clinical Diagnostics, Agriculture & Animal Research, and Drug Discovery & Development), By Technology (NGS, PCR-based, and Microarray), By End-use (Hospitals, Pharmaceuticals, and Research Institutes),-Market Outlook And Industry Analysis 2034" Genomic & Epigenomic Profiling Market Size is
Emerging Trends Influencing The Growth Of The Genomic Biomarker Market: Technolo …
The Genomic Biomarker Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. How Big Is the Genomic Biomarker Market Size Expected to Be by 2034? The size of the genomic biomarker market has witnessed swift expansion in the recent past. It is slated to expand from a
Genomic Biomarker Market Future Business Opportunities 2025-2032 | Liquid Genomi …
Latest Report, titled "Genomic Biomarker Market" Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The Genomic Biomarker market has been expanding significantly
Lipid-Nanoparticle Based Genomic Medicines Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Lipid-Nanoparticle Based Genomic Medicines Market - (By Type (Liposome-based Nanoparticles, Micelle-based Nanoparticles, Lipid-Coated Nanoparticles), By Application (Cancer Treatment, Infectious Diseases, Genetic Disorders, Cardiovascular Diseases, Others), By Therapeutic Payload (mRNA-based Therapeutics, siRNA-based Therapeutics, miRNA-based Therapeutics, Other Genomic Medicines), By End-User (Hospitals, Biopharmaceutical Companies, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the